Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

A pair for companion diagnostics
September 2015
SHARING OPTIONS:

DEQING & SHANGHAI, China—Shuwen Biotech Co. Ltd. has paired with Jiangsu Hengrui Medicine Co. Ltd. in a collaboration agreement, under which Shuwen Biotech will develop companion diagnostic assays and kits for an unidentified anticancer drug candidate being developed by Hengrui. In addition, Shuwen will screen patients at its diagnostic reference labs using the assays for Hengrui's clinical trials. Should the diagnostic kit receive regulatory approval, Shuwen will be responsible for manufacturing and marketing the kit. No financial details were disclosed.
 
“Hengrui Medicine is a leader in targeted therapies for cancer with a full pipeline of innovative drugs in development,” commented Jay Z. Zhang, chairman and CEO of Shuwen Biotech. “This partnership is testimony to the expertise and full capabilities in companion diagnostics we can provide in development, manufacturing, marketing and testing services to our partners and eventually physicians and patients.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.